Matrix metalloproteinase 12 silencing: A therapeutic approach to treat pathological lung tissue remodeling?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Birkedal-Hansen, 1993, Matrix metalloproteinases: a review, Crit Rev Oral Biol Med, 4, 197, 10.1177/10454411930040020401
Fu, 2008, Activation and silencing of matrix metalloproteinases, Semin Cell Dev Biol, 19, 2, 10.1016/j.semcdb.2007.06.005
Wu, 2000, Induction and regulation of matrix metalloproteinase-12 by cytokines and CD40 signaling in monocyte/macrophages, Biochem Biophys Res Commun, 269, 808, 10.1006/bbrc.2000.2368
Lavigne, 2004, Human bronchial epithelial cells express and secrete MMP-12, Biochem Biophys Res Commun, 324, 534, 10.1016/j.bbrc.2004.09.080
Lian, 2005, Overexpression of Stat3C in pulmonary epithelium protects against hyperoxic lung injury, J Immunol, 174, 7250, 10.4049/jimmunol.174.11.7250
Xie, 2005, Induction and regulation of matrix metalloproteinase-12 in human airway smooth muscle cells, Respir Res, 6, 148, 10.1186/1465-9921-6-148
Lagente, 2006, Models for chronic obstructive pulmonary disease involving matrix metalloproteinases, Drug Discov Today Dis Models, 3, 231, 10.1016/j.ddmod.2006.10.007
Nenan, 2005, Analysis of the inflammatory response induced by rhMMP-12 catalytic domain instilled in mouse airways, Int Immunopharmacol, 5, 511, 10.1016/j.intimp.2004.10.011
Barnes, 2003, Chronic obstructive pulmonary disease: molecular and cellular mechanisms, Eur Respir J, 22, 672, 10.1183/09031936.03.00040703
Belvisi, 2003, The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?, Inflamm Res, 52, 95, 10.1007/s000110300020
Demedts, 2006, Elevated MMP-12 protein levels in induced sputum from patients with COPD, Thorax, 61, 196, 10.1136/thx.2005.042432
Shapiro, 2002, Proteinases in chronic obstructive pulmonary disease, Biochem Soc Trans, 30, 98, 10.1042/bst0300098
Babusyte, 2007, Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD, Respir Res, 8, 81, 10.1186/1465-9921-8-81
Hogg, 2004, The nature of small-airway obstruction in chronic obstructive pulmonary disease, N Engl J Med, 350, 2645, 10.1056/NEJMoa032158
Shapiro, 1994, Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease, Am J Respir Crit Care Med, 150, S160, 10.1164/ajrccm/150.6_Pt_2.S160
Lavigne, 2005, Cigarette smoke condensate induces MMP-12 gene expression in airway-like epithelia, Biochem Biophys Res Commun, 330, 194, 10.1016/j.bbrc.2005.02.144
Hautamaki, 1997, Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice, Science, 277, 2002, 10.1126/science.277.5334.2002
Maes, 2006, Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation, Int Arch Allergy Immunol, 141, 354, 10.1159/000095462
Molet, 2005, Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease, Inflamm Res, 54, 31, 10.1007/s00011-004-1319-4
Pascual, 2005, Airway remodeling contributes to the progressive loss of lung function in asthma: an overview, J Allergy Clin Immunol, 116, 477, 10.1016/j.jaci.2005.07.011
Beasley, 2002, Airway remodelling in asthma, Clin Exp Allergy Rev, 2, 109, 10.1046/j.1472-9725.2.s4.1.x
Holgate, 2000, Epithelial damage and response, Clin Exp Allergy, 30, 37, 10.1046/j.1365-2222.2000.00095.x
Sarpong, 2003, A novel mouse model of experimental asthma, Int Arch Allergy Immunol, 132, 346, 10.1159/000074902
Pouladi, 2004, Interleukin-13-dependent expression of matrix metalloproteinase-12 is required for the development of airway eosinophilia in mice, Am J Respir Cell Mol Biol, 30, 84, 10.1165/rcmb.2003-0051OC
Chiba, 2007, Increase in the expression of matrix metalloproteinase-12 in the airways of rats with allergic bronchial asthma, Biol Pharm Bull, 30, 318, 10.1248/bpb.30.318
Di Valentin, 2009, New asthma biomarkers: lessons from murine models of acute and chronic asthma, Am J Physiol Lung Cell Mol Physiol, 296, L185, 10.1152/ajplung.90367.2008
Amrani, 1998, Cytokines induce airway smooth muscle cell hyperresponsiveness to contractile agonists, Thorax, 53, 713, 10.1136/thx.53.8.713
Cataldo, 2002, Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation, Am J Pathol, 161, 491, 10.1016/S0002-9440(10)64205-8
Warner, 2004, Role of metalloelastase in a model of allergic lung responses induced by cockroach allergen, Am J Pathol, 165, 1921, 10.1016/S0002-9440(10)63244-0
Lagente, 2005, Role of matrix metalloproteinases in the development of airway inflammation and remodeling, Braz J Med Biol Res, 38, 1521, 10.1590/S0100-879X2005001000009
Shapiro, 1992, Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase, J Biol Chem, 267, 4664, 10.1016/S0021-9258(18)42885-2
Shapiro, 1993, Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages, J Biol Chem, 268, 23824, 10.1016/S0021-9258(20)80459-1
Fu, 2001, Cloning, expression, purification, and characterization of rat MMP-12, Protein Expr Purif, 21, 268, 10.1006/prep.2000.1376
Chen, 2004, MMP-12, an old enzyme plays a new role in the pathogenesis of rheumatoid arthritis?, Am J Pathol, 165, 1069, 10.1016/S0002-9440(10)63368-8
Bertini, 2003, X-ray structures of binary and ternary enzyme-product-inhibitor complexes of matrix metalloproteinases, Angew Chem Int Ed Engl, 42, 2673, 10.1002/anie.200350957
Kerkela, 2001, Human macrophage metalloelastase (MMP-12) expression is induced in chondrocytes during fetal development and malignant transformation, Bone, 29, 487, 10.1016/S8756-3282(01)00595-6
Shapiro, 1998, Matrix metalloproteinase degradation of extracellular matrix: biological consequences, Curr Opin Cell Biol, 10, 602, 10.1016/S0955-0674(98)80035-5
Gronski, 1997, Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase, J Biol Chem, 272, 12189, 10.1074/jbc.272.18.12189
Ashworth, 1999, Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling, Biochem J, 340, 171, 10.1042/0264-6021:3400171
Matsumoto, 1998, Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development, Am J Pathol, 153, 109, 10.1016/S0002-9440(10)65551-4
Shipley, 1996, Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice, Proc Natl Acad Sci U S A, 93, 3942, 10.1073/pnas.93.9.3942
Houghton, 2006, Elastin fragments drive disease progression in a murine model of emphysema, J Clin Invest, 116, 753, 10.1172/JCI25617
Chandler, 1996, Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein, Biochem Biophys Res Commun, 228, 421, 10.1006/bbrc.1996.1677
Belaaouaj, 2000, Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation, J Biol Chem, 275, 27123, 10.1016/S0021-9258(19)61488-2
Dong, 1997, Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma, Cell, 88, 801, 10.1016/S0092-8674(00)81926-1
Cornelius, 1998, Matrix metalloproteinases generate angiostatin: effects on neovascularization, J Immunol, 161, 6845, 10.4049/jimmunol.161.12.6845
Dwivedi, 2006, MMP-12 is important for VSMC proliferation and migration: role of B-catenin signalling, Vascul Pharmacol, 45, e129, 10.1016/j.vph.2006.08.343
Huang, 2008, Wnt/beta-catenin signaling: new (and old) players and new insights, Curr Opin Cell Biol, 20, 119, 10.1016/j.ceb.2008.01.009
Curci, 1998, Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms, J Clin Invest, 102, 1900, 10.1172/JCI2182
Wu, 2001, Induction of human matrix metalloproteinase-12 gene transcriptional activity by GM-CSF requires the AP-1 binding site in human U937 monocytic cells, Biochem Biophys Res Commun, 285, 300, 10.1006/bbrc.2001.5161
Clark, 2008, The regulation of matrix metalloproteinases and their inhibitors, Int J Biochem Cell Biol, 40, 1362, 10.1016/j.biocel.2007.12.006
Feinberg, 2000, Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages, J Biol Chem, 275, 25766, 10.1074/jbc.M002664200
Rosen, 1996, Granulocyte-macrophage colony-stimulating factor preferentially activates the 94-kD STAT5A and an 80-kD STAT5A isoform in human peripheral blood monocytes, Blood, 88, 1206, 10.1182/blood.V88.4.1206.bloodjournal8841206
Lappalainen, 2005, Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung, Am J Respir Cell Mol Biol, 32, 311, 10.1165/rcmb.2004-0309OC
Hoffmann, 2008, Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway, J Biol Chem, 283, 12120, 10.1074/jbc.M800583200
Elias, 2006, State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice, Proc Am Thorac Soc, 3, 494, 10.1513/pats.200603-068MS
Greenlee, 2007, Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted, Physiol Rev, 87, 69, 10.1152/physrev.00022.2006
Lanone, 2002, Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling, J Clin Invest, 110, 463, 10.1172/JCI0214136
Fichtner-Feigl, 2006, IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis, Nat Med, 12, 99, 10.1038/nm1332
Wang, 2005, Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice, Proc Natl Acad Sci U S A, 102, 15791, 10.1073/pnas.0507375102
Horton, 1999, Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages, J Immunol, 162, 4171, 10.4049/jimmunol.162.7.4171
Ito, 2007, Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-beta stimulation via the PI3K/Akt pathway, Exp Gerontol, 42, 532, 10.1016/j.exger.2006.11.012
Xu, 2008, Metalloelastase in lungs and alveolar macrophages is modulated by extracellular substance P in mice, Am J Physiol Lung Cell Mol Physiol, 295, L162, 10.1152/ajplung.00282.2007
Bracke, 2005, Matrix metalloproteinase-12 and cathepsin D expression in pulmonary macrophages and dendritic cells of cigarette smoke-exposed mice, Int Arch Allergy Immunol, 138, 169, 10.1159/000088439
Arikan, 2005, Induction of macrophage elastase (MMP-12) gene expression by statins, J Cell Physiol, 204, 139, 10.1002/jcp.20271
miRBase. <http://microrna.sanger.ac.uk/>.
van Rooij, 2008, Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis, Proc Natl Acad Sci U S A, 105, 13027, 10.1073/pnas.0805038105
Sengupta, 2008, MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins, Proc Natl Acad Sci U S A, 105, 5874, 10.1073/pnas.0801130105
Raza, 2000, Proteinase-activated receptor-1 regulation of macrophage elastase (MMP-12) secretion by serine proteinases, J Biol Chem, 275, 41243, 10.1074/jbc.M005788200
Churg, 2007, Alpha1-antitrypsin suppresses TNF-alpha and MMP-12 production by cigarette smoke-stimulated macrophages, Am J Respir Cell Mol Biol, 37, 144, 10.1165/rcmb.2006-0345OC
Lijnen, 2001, Plasmin and matrix metalloproteinases in vascular remodeling, Thromb Haemost, 86, 324, 10.1055/s-0037-1616230
Pepper, 2001, Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis, Arterioscler Thromb Vasc Biol, 21, 1104, 10.1161/hq0701.093685
Shukla, 2006, Transcriptional up-regulation of MMP12 and MMP13 by asbestos occurs via a PKCdelta-dependent pathway in murine lung, FASEB J, 20, 997, 10.1096/fj.05-4554fje
Grumelli, 2004, An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema, PLoS Med, 1, e8, 10.1371/journal.pmed.0010008
He, 1989, Tissue cooperation in a proteolytic cascade activating human interstitial collagenase, Proc Natl Acad Sci U S A, 86, 2632, 10.1073/pnas.86.8.2632
Carmeliet, 1997, Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation, Nat Genet, 17, 439, 10.1038/ng1297-439
Gossas, 2006, Characterization of Ca2+ interactions with matrix metallopeptidase-12: implications for matrix metallopeptidase regulation, Biochem J, 398, 393, 10.1042/BJ20051933
Gill, 2008, Metalloproteinases and their inhibitors: regulators of wound healing, Int J Biochem Cell Biol, 40, 1334, 10.1016/j.biocel.2007.10.024
Kassim, 2005, NADPH oxidase restrains the matrix metalloproteinase activity of macrophages, J Biol Chem, 280, 30201, 10.1074/jbc.M503292200
Vaalamo, 1999, Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration, J Invest Dermatol, 112, 499, 10.1046/j.1523-1747.1999.00547.x
Saarialho-Kere, 1999, Accumulation of matrilysin (MMP-7) and macrophage metalloelastase (MMP-12) in actinic damage, J Invest Dermatol, 113, 664, 10.1046/j.1523-1747.1999.00731.x
Suomela, 2001, Metalloelastase (MMP-12) and 92-kDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and -3, are expressed in psoriatic lesions, Exp Dermatol, 10, 175, 10.1034/j.1600-0625.2001.010003175.x
Johnson, 2007, Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability, Expert Rev Cardiovasc Ther, 5, 265, 10.1586/14779072.5.2.265
Yamada, 2008, Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits, Am J Pathol, 172, 1419, 10.2353/ajpath.2008.070604
Dong, 1998, Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor, J Exp Med, 188, 755, 10.1084/jem.188.4.755
Gorrin-Rivas, 2000, Implications of human macrophage metalloelastase and vascular endothelial growth factor gene expression in angiogenesis of hepatocellular carcinoma, Ann Surg, 231, 67, 10.1097/00000658-200001000-00010
Yang, 2001, Human macrophage metalloelastase gene expression in colorectal carcinoma and its clinicopathologic significance, Cancer, 91, 1277, 10.1002/1097-0142(20010401)91:7<1277::AID-CNCR1129>3.0.CO;2-H
Kerkela, 2000, Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer, J Invest Dermatol, 114, 1113, 10.1046/j.1523-1747.2000.00993.x
Cuniasse, 2005, Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs, Biochimie, 87, 393, 10.1016/j.biochi.2004.09.025
Bertini, 2005, Conformational variability of matrix metalloproteinases: beyond a single 3D structure, Proc Natl Acad Sci U S A, 102, 5334, 10.1073/pnas.0407106102
Skiles, 2001, The design, structure, and therapeutic application of matrix metalloproteinase inhibitors, Curr Med Chem, 8, 425, 10.2174/0929867013373417
Dive, 2004, Phosphinic peptides as zinc metalloproteinase inhibitors, Cell Mol Life Sci, 61, 2010, 10.1007/s00018-004-4050-y
Hu, 2007, Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases, Nat Rev Drug Discov, 6, 480, 10.1038/nrd2308
Devel, 2006, Development of selective inhibitors and substrate of matrix metalloproteinase-12, J Biol Chem, 281, 11152, 10.1074/jbc.M600222200
Schiodt, 2001, Phosphinic peptide inhibitors of macrophage metalloelastase (MMP-12). Selectivity and mechanism of binding, Curr Med Chem, 8, 967, 10.2174/0929867013372670
Le Quement, 2008, The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke, Br J Pharmacol, 154, 1206, 10.1038/bjp.2008.180
Ma, 2006, Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids, J Med Chem, 49, 456, 10.1021/jm051101g
Mannino, 2006, Synthesis of bicyclic molecular scaffolds (BTAa): an investigation towards new selective MMP-12 inhibitors, Bioorg Med Chem, 14, 7392, 10.1016/j.bmc.2006.07.028
Dublanchet, 2005, Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors, Bioorg Med Chem Lett, 15, 3787, 10.1016/j.bmcl.2005.05.079
Ando, 2007, Synthesis and matrix metalloproteinase (MMP)-12 inhibitory activity of ageladine A and its analogs, Bioorg Med Chem Lett, 17, 4495, 10.1016/j.bmcl.2007.06.005
Fingleton, 2008, MMPs as therapeutic targets – still a viable option?, Semin Cell Dev Biol, 19, 61, 10.1016/j.semcdb.2007.06.006
Cataldo, 2003, Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors, Cell Mol Biol (Noisy-le-grand), 49, 875
Gueders, 2005, Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation, J Immunol, 175, 2589, 10.4049/jimmunol.175.4.2589
de Fougerolles, 2007, Interfering with disease: a progress report on siRNA-based therapeutics, Nat Rev Drug Discov, 6, 443, 10.1038/nrd2310
Filipowicz, 2005, Post-transcriptional gene silencing by siRNAs and miRNAs, Curr Opin Struct Biol, 15, 331, 10.1016/j.sbi.2005.05.006
Valencia-Sanchez, 2006, Control of translation and mRNA degradation by miRNAs and siRNAs, Genes Dev, 20, 515, 10.1101/gad.1399806
Chapman, 2007, Specialization and evolution of endogenous small RNA pathways, Nat Rev Genet, 8, 884, 10.1038/nrg2179
Reynolds, 2006, Induction of the interferon response by siRNA is cell type- and duplex length-dependent, RNA, 12, 988, 10.1261/rna.2340906
Haasnoot, 2007, RNA interference against viruses: strike and counterstrike, Nat Biotechnol, 25, 1435, 10.1038/nbt1369
Popescu, 2005, Antisense- and RNA interference-based therapeutic strategies in allergy, J Cell Mol Med, 9, 840, 10.1111/j.1582-4934.2005.tb00383.x
Elbashir, 2002, Analysis of gene function in somatic mammalian cells using small interfering RNAs, Methods, 26, 199, 10.1016/S1046-2023(02)00023-3
Pei, 2006, On the art of identifying effective and specific siRNAs, Nat Methods, 3, 670, 10.1038/nmeth911
Lu, 2005, In vivo application of RNA interference: from functional genomics to therapeutics, Adv Genet, 54, 117
Omi, 2004, Long-lasting RNAi activity in mammalian neurons, FEBS Lett, 558, 89, 10.1016/S0014-5793(04)00017-1
Corey, 2007, Chemical modification: the key to clinical application of RNA interference?, J Clin Invest, 117, 3615, 10.1172/JCI33483
De Paula, 2007, Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting, RNA, 13, 431, 10.1261/rna.459807
Aigner, 2006, Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs, J Biotechnol, 124, 12, 10.1016/j.jbiotec.2005.12.003
Bumcrot, 2006, RNAi therapeutics: a potential new class of pharmaceutical drugs, Nat Chem Biol, 2, 711, 10.1038/nchembio839
McNamara, 2006, Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras, Nat Biotechnol, 24, 1005, 10.1038/nbt1223
Oliveira, 2006, Targeted Delivery of siRNA, J Biomed Biotechnol, 2006, 63675, 10.1155/JBB/2006/63675
Wiewrodt, 2002, Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells, Blood, 99, 912, 10.1182/blood.V99.3.912
Muro, 2003, A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1, J Cell Sci, 116, 1599, 10.1242/jcs.00367
Stahl, 1998, The mannose receptor is a pattern recognition receptor involved in host defense, Curr Opin Immunol, 10, 50, 10.1016/S0952-7915(98)80031-9
Engering, 1997, The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells, Eur J Immunol, 27, 2417, 10.1002/eji.1830270941
DesJardin, 2002, Mycobacterium tuberculosis-infected human macrophages exhibit enhanced cellular adhesion with increased expression of LFA-1 and ICAM-1 and reduced expression and/or function of complement receptors, FcgammaRII and the mannose receptor, Microbiology, 148, 3161, 10.1099/00221287-148-10-3161
Kanters, 2007, Expression of activated Fc gamma RII discriminates between multiple granulocyte-priming phenotypes in peripheral blood of allergic asthmatic subjects, J Allergy Clin Immunol, 120, 1073, 10.1016/j.jaci.2007.06.021
Park, 2008, Genome-wide profiling of antigen-induced time course expression using murine models for acute and chronic asthma, Int Arch Allergy Immunol, 146, 44, 10.1159/000112502
Acuff, 2006, Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer, Cancer Res, 66, 7968, 10.1158/0008-5472.CAN-05-4279
McIntyre, 2006, Design and cloning strategies for constructing shRNA expression vectors, BMC Biotechnol, 6, 1, 10.1186/1472-6750-6-1
Nakao, 2008, Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease, J Immunol, 180, 6262, 10.4049/jimmunol.180.9.6262
Gene therapy clinical trials worldwide. J Gene Med. <http://www.wiley.co.uk/genmed/clinical/>.
Buning, 2008, Recent developments in adeno-associated virus vector technology, J Gene Med, 10, 717, 10.1002/jgm.1205
Boeckle, 2006, Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems, AAPS J, 8, E731, 10.1208/aapsj080483
Gipps, 1986, Distribution of polyhexyl cyanoacrylate nanoparticles in nude mice bearing human osteosarcoma, J Pharm Sci, 75, 256, 10.1002/jps.2600750310
Bosquillon, 2001, Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance, J Control Release, 70, 329, 10.1016/S0168-3659(00)00362-X
Azarmi, 2008, Targeted delivery of nanoparticles for the treatment of lung diseases, Adv Drug Deliv Rev, 60, 863, 10.1016/j.addr.2007.11.006
Li, 2005, Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque, Nat Med, 11, 944, 10.1038/nm1280
Huang, 2008, Small interfering RNA against interleukin-5 decreases airway eosinophilia and hyper-responsiveness, Gene Ther, 15, 660, 10.1038/gt.2008.15
Lee, 2008, Lentiviral-mediated GATA-3 RNAi decreases allergic airway inflammation and hyperresponsiveness, Mol Ther, 16, 60, 10.1038/sj.mt.6300309
Durcan, 2008, Inhalable siRNA: potential as a therapeutic agent in the lungs, Mol Pharm, 5, 559, 10.1021/mp070048k
Deroanne, 2003, EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway, J Cell Sci, 116, 1367, 10.1242/jcs.00308
Persengiev, 2004, Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs), RNA, 10, 12, 10.1261/rna5160904
Judge, 2008, Overcoming the innate immune response to small interfering RNA, Hum Gene Ther, 19, 111, 10.1089/hum.2007.179
Zamanian-Daryoush, 2008, Determinants of cytokine induction by small interfering RNA in human peripheral blood mononuclear cells, J Interferon Cytokine Res, 28, 221, 10.1089/jir.2007.0090
Sioud, 2008, Does the understanding of immune activation by RNA predict the design of safe siRNAs?, Front Biosci, 13, 4379, 10.2741/3011
Yang, 2007, Connective tissue growth factor increases matrix metalloproteinase-2 and suppresses tissue inhibitor of matrix metalloproteinase-2 production by cultured renal interstitial fibroblasts, Wound Repair Regen, 15, 817, 10.1111/j.1524-475X.2007.00284.x
Emi, 1991, Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus, J Virol, 65, 1202, 10.1128/JVI.65.3.1202-1207.1991